Blue Horseshoe Stocks: Options Roundup & More

Options Review

Apple, Inc. AAPL  – AAPL beat on earnings as well as kicking off sales on the iPhone X, and two out of three of the AAPL Weekly $170-175 Calls* we signaled for possible daytrades ended up recording some nice moves on the day.

Our first order of business to kick off the fresh week is to recap those moves followed by another set of winners we chose on Friday.

The AAPL $170 Calls ran from 1.63-3.82 for potential gains of up to 135%, while the , $172.50s made an even nicer move from .31 to 1.36 for an intraday rip of 339%

____

Arista Networks, Inc. ANET  - The set of ideas we formulated for ANET on Friday were the 11/17 $195-210 Calls, and all three sets of contracts in that range provided traders with the chance at multi-bag intraday gains.

$195 Calls – Range: 3.15-9.30 – Max Gain: 195%
$200 Calls – Range: 2.40-5.80 – Max Gain: 142%
$210 Calls – Range: 1.00-2.11 – Max Gain: 111%

____

Fresh Idea:

For a new potential play, we’re looking at Pandora Media, Inc. P which took a gut punch on Friday, falling to its lowest prices since early this summer. The last time the stock was this oversold, it followed it up with a run from 6.75 to to 10.00.

We’re going to go out a couple of months on the expiration and track the  P 01/19 $6 and $7 Calls so we have plenty of time to see Pandora make the rebound we’re after.


Keryx Biopharmaceuticals, Inc. KERX

We’re going to put KERX on watch after noticing multiple ripe indicators this morning. The stock bounced of a recent bottom and close with strength at the 200DMA on Friday. With the MACD gearing up for a bullish cross and the RSI just about to crack the 50-line, we’ll be interested to track the activity in KERX in coming sessions.


Extended Watchlist:
HMNY, EVEP, KORS, PTN, AMD, EGLT, NTES

Blue Horseshoe Stocks: NIHD Review & More

NII Holdings, Inc. NIHD

We initially tagged NIHD in our premarket report from last Thursday, and on that day we would observe a low of .5472 in the stock. It’s been stepping its way up, but this morning in premarket trading things have really kicked into high gear, with NIHD cracking through the dollar barrier.

As of this morning’s premarket high of 1.14, we’ve now witnessed an increase of 108% in NIHD over a span of just three trading sessions. In order for us to remain highly interested in this play, we’ll want to see it maintain support at or above its current 50DMA of .83 on any pullbacks that may occur.


Celsion Corp. CLSN

We called out CLSN in yesterday morning’s premarket report, and saw a modest yet respectable move out of that play as well. From a low of 3.85 the stock ran as high as 4.96, marking an intraday move of 29%

The stock was number four on the NASDAQ’s top gainer list for the day, and while it did end up tapering back to close near its daily lows, this morning it is gapping up again in the premarket. This surge of activity is primarily due to yesterday’s announcement of positive results in its ovarian cancer treatment trials.

We’ll definitely be keeping CLSN on our radars and watching for the continued establishment of higher lows off of our recently observed bottom.


Bitcoin Services, Inc. BTSC

BTSC was a part of the bitcoin watchlist we issued on May 25th in the midst of a bitcoin frenzy where the crypto-currency was soaring to new all-time highs.

The residual effect for plays like BTSC has been impressive, with with stocks PPS making a jump from our observed low of  .0366 up to a new high of .164 yesterday, which represents a 348% rip which occurred over a period of just seven sessions.


Egalet Corp. EGLT

Not only is EGLT coming off of a bottom on the chart, but in the space of the past 36 hours, the company has made two major announcements.

Yesterday, it was made known that EGLT had “received a U.S. patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.” (>>View PR)

Today, the announcement was that “one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets” (>>View PR)


Extended Watchlist:
KMI, GAHC, EBIO, GALT, IAG, BLDP, SBGL